← Open Payments lookup

GERI IAMES: Open Payments

NPI 1144792961 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$353 in 14 payments from 13 companies in 2025. Trend: 2023 $186 · 2024 $957 · 2025 $353

Food & beverage: $353
CompanyPaymentsAmount
Incyte Corporation2$52
PFIZER INC.1$29
BeOne Medicines USA, Inc.1$29
Genentech USA, Inc.1$28
Janssen Biotech, Inc.1$28
Iovance Biotherapeutics, Inc.1$27
Gilead Sciences, Inc.1$26
BeiGene USA, Inc.1$25
Daiichi Sankyo Inc.1$25
Novartis Pharmaceuticals Corporation1$23

Products named: TEVIMBRA, IBRANCE, Itovebi, MONJUVI, CARVYKTI, Amtagvi, Trodelvy, JAKAFI.

Industry payments across MD — which companies pay providers there.